Pfizer wants to give children aged 5 to 11 COVID-19 vaccine booster

Pfizer is planning to ask the Food and Drug Administration (FDA) to give its Wuhan coronavirus (COVID-19) vaccine an emergency use authorization as a booster for children aged five to 11. The Big Pharma company’s basis for asking comes from phase 2 and 3 clinical trial data that claims to show that giving children aged five to 11 a … Continue reading Pfizer wants to give children aged 5 to 11 COVID-19 vaccine booster